Stage IV Childhood Small Noncleaved Cell Lymphoma Completed Phase 2 Trials for Tacrolimus (DB00864)

IndicationStatusPhase
DBCOND0030352 (Stage IV Childhood Small Noncleaved Cell Lymphoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00089011Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerTreatment